Get Permission Patel, Ahmed, Hasan, and Hasan: Clinicopathological profile of triple negative breast cancer in a tertiary health care centre of India


Introduction

Breast cancer accounts for 11.6% cases of all malignancy with 2.1 million cases of newly diagnosed female breast cancer cases in the year 2018.1 In India, Breast cancer is the most common cancer in women and accounts for 27% of all cancer in women. 2 Triple Negative Breast Carcinomas (TNBCs) are group of tumors that does not express the genes for Estrogen receptor (ER), Progesterone receptor (PR), and Human epidermal growth factor receptor 2 (HER2/neu), accounting for 15-20% of all breast carcinomas.3 Prevalence of TNBC in India is considerably higher as compared to Western countries with a ratio of 1:3 having a triple-negative disease. 4 TNBCs are highly aggressive subtype of breast cancer, majorities are in young aged patients, are of high grade with limited treatment options and very poor prognosis.5 Few of the risk factors associated with TNBC are prior history of breast cancer, Asian ancestry, and a BRCA1 or BRCA2 mutation.6 Thus , this study the clinicopathological features of triple negative breast carcinoma by histomorphological features of triple negative breast cancer; analysing various parameters such as the age, site, tumour size, clinical features and treatment outcomes in triple negative breast cancer; and by comparing these clinicopathological features in luminal A, luminal B, Her2 positive and triple negative tumours.

Materials and Methods

This study was a four year retrospective study which was carried out on two hundred eight cases of breast carcinoma and was undertaken in the Department of Pathology. Complete clinical details including history, clinical examination, gross examination along with relevant investigations were recorded in each case. Related paraffin blocks were obtained from the record section and routine Haematoxylin and eosin (H & E) staining and immunohistochemical studies were done. The tumours were classified as Luminal A (HR +ve, HER2/neu-ve), Luminal B (HR +ve, HER2/neu +ve), Her 2 Positive (HR -ve, HER2/neu +ve) and Triple negative breast Cancer (HR -ve, HER2/neu-ve). Out of two hundred and eight cases, ninety seven cases were of triple negative cancer. The clinicopathological details and histomorphological features of TNBCs were reviewed. The morphological parameters analysed were tumour size, tumour site, histological type, histological grade, lymph node status and the stage (TNM staging) along with lymphovascular and nodal involvement. The study was approved by Institutional Ethics Committee.

Inclusion criteria

Specimen labeled as TNBC.

Exclusion criteria

Tissues not enough for immunostaining, prior chemotherapy or radiotherapy.

Observations and Results

In the present study, most of the cases were premenopausal women i.e. 59 (60.8%) and 38 (39.1%) cases were postmenopausal women. (Figure 1) Highest incidence of TNBC cases were observed in age group of 41-50 years (42%) followed by 23.7% cases in age group of 31-40 years. Least cases were distributed in the age group of 60 years and above. (Figure 2).

Majority of the cases occurred in the right breast (52%) while 48% occurred in the left breast.(Figure 3) Most common site involved in our study was upper outer quadrant, in 61/97 (70.1%) cases, followed by upper inner quadrant in 12 (12.4%) cases. (Table 1)

Most of the TNBC cases in our study have size of between 2 to 5 cm in diameter i.e. in 65/97 (67.0%) of TNBC cases followed by tumor size >5cm in 16/97 (19.3%) cases and only 5/97 (5.2%) cases had size ≤2cm. (Figure 4).

Out of 97 TNBC cases, 92 (94.8%) cases are diagnosed with invasive carcinoma (NST) and 3 (3.1%) case of carcinoma with medullary features and 2 (2.1%) case of metaplastic carcinoma. (Table 2). Among 97 TNBC cases, 64(66.0%) cases were of grade 3, 30 (30.9%) cases were of grade 2 and rest 3(3.1%) cases were of grade 1. (Figure 5). Lympho-vascular invasion were found in 24.7%TNBC cases whereas, no evidence of tumor cells in lympho-vascular channel was found in 75.3% TNBC cases. Out of 97 TNBC cases, we received 71 cases along with lymph nodes. Among these 71 TNBC cases, 44 (62%) cases were found to be lymph node positive for tumor cells while rest 27 (38%) were negative for any lymph node involvement by tumor cells. (Table 3). Out of 44 lymph node(s) positive cases, 1-3 lymph nodes metastasis was seen in 30 (68.2%) cases,. 4 to 9 lymph nodes were involved in 11 (25.0%) cases and ≥10 lymph nodes were involved in 3 (6.8%) cases. Out of 71 TNBC lymph node positive TNBC cases, 36 (50.7%) were of stage II, followed by 33 (46.5%) cases were of stage III and rest 2 (2.8%) cases were of stage I. Out of 71 TNBC cases most cases are of stage IIB, 22 (31.0%) followed by equal number of stage IIA and stage IIIA i.e.16 (22.5%) then stage IIIB, 12 (16.9%) > stage IIIC, 3 (4.2%) > stage IA 2 (2.8%) and no cases are of stage IB.

Table 1

Showing distribution of TNBC cases according to the quadrant of the breast involved

Site

Number of cases

Upper Outer Quadrant

61 (70.1%)

Upper Inner Quadrant

12 (12.4%)

Lower Outer Quadrant

8(8.3%)

Lower Inner Quadrant

4(4.1%)

Central

5 (5.1%)

Total

97 (100%)

Table 2

Distribution of TNBC cases according to the histopathological type

Histomorphological Type

Number of cases

Invasive Ductal Carcinoma

92 (94.8%)

Metaplastic Carcinoma

2 (2.1%)

Carcinoma with Medullary like Features

3 (3.1%)

Total

97

Table 3

Showing distribution of TNBC cases according to the lympho-vascular invasion and lymph node involvement

Lymphovascular invasion

Number of cases

Present

24 (24.7%)

Absent

73 (75.3%)

Total

97

Lymph Node(s) Involvement

Number of cases

Present

44 (62%)

Absent

27 (38%)

Total

71

Table 4

Distribution of TNBC cases according to the stage

TNM stage

Total number of cases

I

IA

2 (2.8%)

IB

0 (0%)

Total

2 (2.8%)

II

IIA

16 (22.5%)

IIB

22 (31.0%)

Total

36 (50.7%)

III

IIIA

16 (22.5%)

IIIB

12 (16.9%)

IIIC

3 (4.2%)

Total

33 (46.5%)

Total

97 (100%)

Figure 1

Showing TNBC cases distribution according to menopausal status

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/30ce9f45-da72-430d-8b45-f0ff819c4295image1.png
Figure 2

Showing distribution of TNBC cases according to the age

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/30ce9f45-da72-430d-8b45-f0ff819c4295image2.png
Figure 3

Showing distribution of TNBC cases according to the laterality of the breast involved

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/30ce9f45-da72-430d-8b45-f0ff819c4295image3.png
Figure 4

Showing distribution of TNBC cases according to the tumor size.

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/30ce9f45-da72-430d-8b45-f0ff819c4295image4.png
Figure 5

Showing distribution of TNBC cases according to the SBR grade

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/30ce9f45-da72-430d-8b45-f0ff819c4295image5.png

Discussion

In this study, TNBC cases was found to be more common in premenopausal women 68.0%. similar to a study in southern India with 72.6% of patients below 50 years of age. 5 However, Liu Yin et al., found that 53.1% cases were in postmenopausal women 7 edian age of 45 year was a similar finding in similar studies by Lakshmaiah et al. 5 Higher incidence of TNBC was seen in the right breast similar to studies by Suresh et al.,8 but Left sided TNBC cases were more in studies done by Lakshmaiah et al.,5 but no bilateral cases noted. This showed that the occurrence of bilateral TNBC is higher in Western females as compared to Indian females. Upper outer quadrant followed by upper inner quadrant is found to be a common site for occurance of TNBCs.9, 10 Most common tumor size in our study was found to be size of 2 to 5 cm (67.0%) similar to study by Nassima et al., with majority of patients having a tumor larger than 3 cm. Most common histopathological type of the TNBC in this study was invasive carcinoma (NST) i.e. (94.8%) similar findings were observed by Lakshmaiah et al.,5 Pareja et al.,2016 11 with infiltrating ductal carcinoma (93.54%) as the most common type.TNBC of Grade 3 followed by 2 and 1 are the usual findings12 but grade 2 is found be more common in some studies.13 Triple Negative Breast Carcinoma is found to have an increased association with lympho-vascular invasion as compared to non TNBC cases.14 Similarly Lymph node involvement is found to be more common in TNBC as compared to non TNBC cases.5 However in a similar study by LiuYin et al., majority of cases were node-negative.7 Most of the TNBC cases are associated with 1-3 lymph node(s) (N1) involvement similar to our study.5 TNM stage II is the most common stage of the TNBC similar to study by Lakshmaiah et al.5 However, Agarwal et al., 2015 observed TNM stage III to be the most common stage in 47.5% of the TNBC cases.14

Conclusion

TNBC are common in premenopausal women with a median age of 45 years showing a greater involvement of right breast in the upper outer quandrant usually ranging between the size of >2 - ≤5 cm. TNBCs are usually associated with a higher grade and shows lymphovascular and nodal involvement and thus a overall poor prognosis. Infiltrating ductal carcinoma (not otherwise specified) type (94.8%) was the most common histomorphological type in TNBC cases.

Source of Funding

None.

Conflict of Interest

None.

References

1 

F Bray J Ferlay I Soerjomataram RL Siegel LA Torre A Jemal Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesCA Cancer J Clin2018686394424

2 

The burden of cancers and their variations across the states of India: the Global Burden of Disease Study 1990-2016Lancet Oncol201819101289306

3 

JQ Chen J Russo ERalpha-negative and triple negative breast cancer: molecular features and potential therapeutic approachesBiochim Biophys Acta2009179621627510.1016/j.bbcan.2009.06.003

4 

GS Sandhu S Erqou H Patterson A Mathew Prevalence of Triple-Negative Breast Cancer in India: Systematic Review and Meta-AnalysisJ Glob Oncol20162641221

5 

KC Lakshmaiah U Das TM Suresh D Lokanatha GK Babu LJ Jacob A Study of Triple Negative Breast Cancer at a Tertiary Cancer Care Center in Southern IndiaAnn Med Health Sci Res2014469337

6 

J Yeh J Chun S Schwartz A Wang E Kern AA Guth Clinical Characteristics in Patients with Triple Negative Breast CancerInt J Breast Cancer2017179614510.1155/2017/1796145

7 

L Yin H Shuang C Sheng H Liang XJ Sun WT Yang The Prognostic Value of Nodal Staging in Triple-Negative Breast Cancer - A Cohort from ChinaSci Rep201881900710.1038/s41598-018-23999-8

8 

P Suresh U Batra D C Doval Epidemiological and clinical profile of triple negative breast cancer at a cancer hospital in North IndiaIndian J Med Paediatr Oncol20133428995

9 

S Rummel E Varner C D Shriver RE Ellsworth Evaluation of BRCA1 mutations in an unselected patient population with triple-negative breast cancerBreast Cancer Res Treat201313711192510.1007/s10549-012-2348-2

10 

B Nassima D Jessie D Jed D Chloe E Joel C Virginie Triple negative breast cancer: Early stages management and evolution, a two years’ experience at the department of breast cancer of CHSFClin J Obstet Gynecol20203657810.29328/journal.cjog.1001052

11 

F Pareja F Geyer C Marchiò Triple-negative breast cancer: the importance of molecular and histologic subtyping, and recognition of low-grade variantsBreast Cancer201621603610.1038/npjbcancer.2016.36

12 

EA Rakha ME El-Sayed AR Green AH Lee JF Robertson IO Ellis Prognostic markers in triple-negative breast cancerCancer200710912532

13 

C Rao J Shetty H L Prasad Immunohistochemical profile and morphology in triple-negative breast cancersJournal of Clinical and Diagnostic Research201377136165

14 

G Agarwal G Nanda P Lal A Mishra A Agarwal V Agrawal Outcomes of Triple-Negative Breast Cancers (TNBC) Compared with Non-TNBC: Does the Survival Vary for All Stages?World J Surg2016406136272



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

  • Article highlights
  • Article tables
  • Article images

Article History

Received : 13-07-2023

Accepted : 02-08-2023


View Article

PDF File   Full Text Article


Copyright permission

Get article permission for commercial use

Downlaod

PDF File   XML File   ePub File


Digital Object Identifier (DOI)

Article DOI

https://doi.org/10.18231/j.jdpo.2023.032


Article Metrics






Article Access statistics

Viewed: 590

PDF Downloaded: 561



Medical Abbreviation List